Evidence map›Paper›PMID 27911940›Full record

ArticlePloS one2016

Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice.

Jamie D Weyandt, John M Carney, Elizabeth N Pavlisko, MengMeng Xu, Christopher M Counter

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jamie D WeyandtDepartment of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, North Carolina, United States of America.
John M CarneyDepartment of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America.
Elizabeth N PavliskoDepartment of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America.
MengMeng XuDepartment of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, North Carolina, United States of America.
Christopher M CounterDepartment of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, North Carolina, United States of America.
Duke Medical Center · USDuke University Hospital · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
Dynamic requirements of Ras signaling during cancerR01CA123031 · NCI · DUKE UNIVERSITY · PI COUNTER, CHRISTOPHER M · 2007 to 2018
$3.5M
NCI NIH HHS R01 CA123031NIGMS NIH HHS T32 GM007171
6 · The paper itself

Abstract

The gene KRAS is commonly mutated in lung cancer to encode a constitutively active and oncogenic protein that is well established to initiate and maintain lung tumorigenesis. However, the remaining wild-type KRAS protein, or the other family members HRAS and NRAS, can still be activated in the presence of oncogenic KRAS. Moreover, loss of any one of these three genes has been shown to increase the sensitivity of mice to the carcinogen urethane, which induces Kras mutation-positive early lung lesions. To determine the contribution of progressively disrupting Hras and Nras genes on urethane lung tumorigenesis, mice with different combinations of wild-type and null alleles of Hras and Nras were exposed with urethane and tumor burden was assessed. As previously reported, loss of one allele of Hras increased the sensitivity of mice to this carcinogen, and this effect was further exacerbated by the loss of the second Hras allele. However, loss of one or both alleles of Nras failed to alter tumor burden, either in the absence or presence of Hras, after exposure to urethane. Additionally, no obvious difference between lung lesions in mice with wild-type versus null alleles was detected, suggesting that wild-type Ras proteins may exert a tumor suppressive effects at the time of initiation, although other interpretations are certainly possible. In summary, these data suggest that in some genetic backgrounds inactivation of different wild-type Ras genes can have different effects on urethane-induced lung tumorigenesis.

Indexed as

AllelesCell Transformation, NeoplasticLung NeoplasmsNeoplasms, ExperimentalProto-Oncogene Proteins p21(ras)Tumor Suppressor ProteinsAnimalsIsoenzymesMiceMice, KnockoutUrethaneIsoenzymesProto-Oncogene Proteins p21(ras)Tumor Suppressor ProteinsUrethane

Identifiers

PMID27911940
PMCPMC5135096
OpenAlexW2558255316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.